{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:48:29Z","timestamp":1794451709256,"version":"4.9.1"},"publisher-location":"Boston, MA","reference-count":134,"publisher":"Springer US","isbn-type":[{"value":"9781489917447","type":"print"},{"value":"9781489917423","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/978-1-4899-1742-3_18","type":"book-chapter","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T12:47:28Z","timestamp":1373287648000},"page":"325-344","source":"Crossref","is-referenced-by-count":7,"title":["Reducing the Desire to Drink"],"prefix":"10.1007","author":[{"given":"Raye Z.","family":"Litten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"18_CR1","first-page":"99","volume-title":"Alcoholism: Biomedical and Genetic Aspects","author":"B Tabakoff","year":"1989","unstructured":"Tabakoff B, Hoffman PL: Adaptive responses to ethanol in the central nervous system, in Goedde HE, Agarwal DP (eds): Alcoholism: Biomedical and Genetic Aspects. Elmsford, NY, Pergamon Press, 1989. pp 99\u2013112."},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0741-8329(90)90005-W","volume":"7","author":"WJ McBride","year":"1990","unstructured":"McBride WJ, Murphy JM, Lumeng L, et al: Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol 7:199\u2013205, 1990.","journal-title":"Alcohol"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0741-8329(92)90004-T","volume":"9","author":"K Yoshimoto","year":"1991","unstructured":"Yoshimoto K, McBride WJ, Lumeng L, et al: Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 9:17\u201322, 1991.","journal-title":"Alcohol"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archpsyc.1989.01810030037005","volume":"46","author":"L Buydens-Branchey","year":"1989","unstructured":"Buydens-Branchey L, Branchey MH, Noumair D, et al: Age of alcoholism onset: II. Relationship to susceptibility to serotonin precursor availability. Arch Gen Psychiatry 46:231\u2013236, 1989.","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/0006-3223(91)90122-3","volume":"30","author":"MA Lee","year":"1991","unstructured":"Lee MA, Meltzer HY: Neuroendocrine responses to serotonergic agents in alcoholics. Biol Psychiatry 30:1017\u20131030, 1991.","journal-title":"Biol Psychiatry"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/archpsyc.1991.01810280099018","volume":"48","author":"C Benkelfat","year":"1991","unstructured":"Benkelfat C, Murphy DL, Hill JL, et al: Ethanol-like properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:383, 1991.","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1600-0447.1990.tb06451.x","volume":"81","author":"D Bailly","year":"1990","unstructured":"Bailly D, Vignau J, Lauth B, et al: Platelet serotonin decrease in alcoholic patients. Acta Psychiatr Scand 81:68\u201372, 1990.","journal-title":"Acta Psychiatr Scand"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/archpsyc.1979.01780020114013","volume":"36","author":"JC Ballenger","year":"1979","unstructured":"Ballenger JC, Goodwin FK, Major LF, et al: Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 36:224\u2013227, 1979.","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4899-1678-5_12","volume-title":"Recent Developments in Alcoholism","author":"K Gill","year":"1989","unstructured":"Gill K, Amit Z: Serotonin uptake blockers and voluntary alcohol consumption: A review of recent studies, in Galanter M (ed): Recent Developments in Alcoholism. New York, Plenum Press, 1989. vol 7, pp 225\u2013248."},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4899-1678-5_14","volume-title":"Recent Developments in Alcoholism","author":"DA Gorelick","year":"1989","unstructured":"Gorelick DA: Serotonin uptake blockers and the treatment of alcoholism, in Galanter M (ed): Recent Developments in Alcoholism. New York, Plenum Press, 1989. vol 7, pp 267\u2013281."},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/0091-3057(88)90137-2","volume":"30","author":"WJ McBride","year":"1988","unstructured":"McBride WJ, Murphy JM, Lumeng L, et al: Effects of RO 15-4513, fluoxetine and desipramine on the intake of ethanol, water and food by alcohol-preferring (P) and-nonpreferring (NP) lines of rats. Pharmacol Biochem Behav 30:1045\u20131050, 1988.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/clpt.1984.46","volume":"35","author":"CA Naranjo","year":"1984","unstructured":"Naranjo CA, Sellers EM, Roach CA, et al: Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers. Clin Pharmacol Ther 35:374\u2013381, 1984.","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/clpt.1987.27","volume":"41","author":"CA Naranjo","year":"1987","unstructured":"Naranjo CA, Sellers EM, Sullivan JT, et al: The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41:266\u2013274, 1987.","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/clpt.1989.142","volume":"46","author":"CA Naranjo","year":"1989","unstructured":"Naranjo CA, Sullivan JT, Kadlec K, et al: Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 46:301\u2013309, 1989.","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/clpt.1990.62","volume":"47","author":"CA Naranjo","year":"1990","unstructured":"Naranjo CA, Kadlec KE, Sanhueza P, et al: Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 47:490\u2013498, 1990.","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR16","first-page":"189","volume-title":"Research Advances in New Psychopharmacological Treatments for Alcoholism","author":"Z Amit","year":"1985","unstructured":"Amit Z, Brown Z, Sutherland A, et al: Reduction in alcohol intake in humans as a function of treatment with zimelidine: Implications for treatment, in Naranjo CA, Sellers EM (eds): Research Advances in New Psychopharmacological Treatments for Alcoholism. Amsterdam, Excerpta Medica, 1985. pp 189\u2013198."},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1530-0277.1992.tb01373.x","volume":"16","author":"DA Gorelick","year":"1992","unstructured":"Gorelick DA, Paredes A: Effects of fluoxetine on alcohol consumption in male alcoholics. Alcoholism Clin Exp Res 16:261\u2013265, 1992.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR18","first-page":"367","volume":"16","author":"JD Higley","year":"1992","unstructured":"Higley JD, Hasert MF, Dodson A, et al: Treatment of excessive alcohol consumption using the serotonin reuptake inhibitor sertraline. Alcoholism Clin Exp Res 16:367, 1992.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/00005053-197808000-00003","volume":"166","author":"M Pottenger","year":"1978","unstructured":"Pottenger M, McKernon J, Patrie LE, et al: The frequency and persistence of depressive symptoms in the alcohol abuser. J Nerv Ment Dis 166:562\u2013570, 1978.","journal-title":"J Nerv Ment Dis"},{"key":"18_CR20","first-page":"410","volume-title":"Behavioral Medicine: Changing Health Lifestyles","author":"GA Marlatt","year":"1980","unstructured":"Marlatt GA, Gordon JR: Determinants of relapse: Implications for the maintenance of behavior change, in Davidson PO, Davidson SM (eds): Behavioral Medicine: Changing Health Lifestyles. New York, Brunner\/Mazel, 1980. pp 410\u2013452."},{"key":"18_CR21","first-page":"661","volume-title":"Serotonin uptake inhibitors: Ideal pharmacotherapy for relapse prevention in alcoholics","author":"H Kranzler","year":"1989","unstructured":"Kranzler H, Gorelick DA: Serotonin uptake inhibitors: Ideal pharmacotherapy for relapse prevention in alcoholics, in Waahlberg RB (ed): Proceedings of the 35th International Congress on Alcoholism and Drug Dependence: Prevention and Control\/Realities and Aspirations, vol 2. Norway, National Directorate for the Prevention of Alcohol and Drug Problems, 1989, pp 661\u2013670."},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1530-0277.1986.tb05060.x","volume":"10","author":"MS Goldman","year":"1986","unstructured":"Goldman MS: Neuropsychological recovery in alcoholics: Endogenous and exogenous process. Alcoholism Clin Exp Res 10:136\u2013144, 1986.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1037\/0022-006X.55.3.310","volume":"55","author":"I Grant","year":"1987","unstructured":"Grant I: Alcohol and the brain: Neuropsychological correlates. J Consult Clin Psychol 55:310\u2013324, 1987.","journal-title":"J Consult Clin Psychol"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0740-5472(88)90019-0","volume":"5","author":"SM Gordon","year":"1988","unstructured":"Gordon SM, Kennedy BP, McPeake JD: Neuropsychologically impaired alcoholics: Assessment, treatment considerations, and rehabilitation. J Substance Abuse Treat 5:99\u2013104, 1988.","journal-title":"J Substance Abuse Treat"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/0024-3205(83)90286-2","volume":"33","author":"H Weingartner","year":"1983","unstructured":"Weingartner H, Buchsbaum MS, Linnoila M: Zimelidine effects on memory impairments produced by ethanol. Life Sci 33:2159\u20132163, 1983.","journal-title":"Life Sci"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.1989.01810070043008","volume":"46","author":"PR Martin","year":"1989","unstructured":"Martin PR, Adinoff B, Eckardt MJ, et al: Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Arch Gen Psychiatry 46:617\u2013621, 1989.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"18_CR27","first-page":"55","volume":"52","author":"Z Amit","year":"1991","unstructured":"Amit Z, Smith BR, Gill K: Serotonin uptake inhibitors: Effects on motivated consummatory behaviors. J. Clin Psychiatry 52(12, suppl):55\u201360, 1991.","journal-title":"J. Clin Psychiatry"},{"issue":"12","key":"18_CR28","first-page":"49","volume":"52","author":"EM Sellers","year":"1991","unstructured":"Sellers EM, Higgins GA, Tomkins DM, et al: Opportunities for treatment of psychoactive substance use disorders with serotonergic medications. J Clin Psychiatry 52(12, suppl):49\u201354, 1991.","journal-title":"J Clin Psychiatry"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0741-8329(88)90066-3","volume":"5","author":"JM Murphy","year":"1988","unstructured":"Murphy JM, Waller MB, Gatto GJ, et al: Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats. Alcohol 5:283\u2013286, 1988.","journal-title":"Alcohol"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0091-3057(85)90438-1","volume":"23","author":"DP Taylor","year":"1985","unstructured":"Taylor DP, Eison MS, Riblet LA, et al: Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 23:687\u2013694, 1985.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000284626","volume":"22","author":"F Bruno","year":"1989","unstructured":"Bruno F: Buspirone in the treatment of alcoholic patients. Psychopathology 22(1, suppl):49\u201359, 1989.","journal-title":"Psychopathology"},{"key":"18_CR32","first-page":"52","volume":"47","author":"AA Olivera","year":"1990","unstructured":"Olivera AA, Sarvis S, Heard C: Anxiety disorders coexisting with substance dependence: Treatment with buspirone. Curr Ther Res 47:52\u201361, 1990.","journal-title":"Curr Ther Res"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0741-8329(87)90060-7","volume":"4","author":"DM Collins","year":"1987","unstructured":"Collins DM, Myers RD: Buspirone attenuates volitional alcohol intake in the chronically, drinking monkey. Alcohol 4:49\u201356, 1987.","journal-title":"Alcohol"},{"key":"18_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0741-8329(88)90012-2","volume":"5","author":"TH Privette","year":"1988","unstructured":"Privette TH, Hornsby RL, Myers RD: Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol 5:147\u2013152, 1988.","journal-title":"Alcohol"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00004714-198904000-00027","volume":"9","author":"HR Kranzler","year":"1989","unstructured":"Kranzler HR, Meyer RE: an open trial of buspirone in alcoholics. J Clin Psychopharmacol 9:379\u2013380, 1989.","journal-title":"J Clin Psychopharmacol"},{"key":"18_CR36","unstructured":"Kranzler HR: Serotonergic agonists as adjuncts to relapse prevention in alcoholics. Presented at the Research Society of Alcoholism Meeting, San Diego, June 1992."},{"key":"18_CR37","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1530-0277.1992.tb00691.x","volume":"16","author":"R Malcolm","year":"1992","unstructured":"Malcolm R, Anton KF, Randall CL, et al: A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism Clin Exp Res 16:1007\u20131013, 1992.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0006-8993(90)91103-N","volume":"513","author":"LH Jiang","year":"1990","unstructured":"Jiang LH, Ashby CR, Kasser RJ, et al: The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res 513:156\u2013160, 1990.","journal-title":"Brain Res"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0006-8993(91)90050-6","volume":"543","author":"J Chen","year":"1991","unstructured":"Chen J, van Praag HM, Gardner EL: Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543:354\u2013357, 1991.","journal-title":"Brain Res"},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.2903550","volume":"242","author":"GF Koob","year":"1988","unstructured":"Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 242:715\u2013723, 1988.","journal-title":"Science"},{"key":"18_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4899-1678-5_10","volume-title":"Recent Developments in Alcoholism","author":"WJ McBride","year":"1989","unstructured":"McBride WJ, Murphy JM, Lumeng L, et al: Serotonin and ethanol preference, in Galanter M (ed): Recent Developments in Alcoholism. New York, Plenum Press, 1989. vol 7, pp 187\u2013209."},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0014-2999(89)90259-8","volume":"164","author":"E Carboni","year":"1989","unstructured":"Carboni E, Acquas E, Frau R, et al: Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol 164:515\u2013519, 1989.","journal-title":"Eur J Pharmacol"},{"key":"18_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2999(90)90015-X","volume":"187","author":"KM Wozniak","year":"1990","unstructured":"Wozniak KM, Pert A, Linnoila M: Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine. Eur J Pharmacol 187:287\u2013289, 1990.","journal-title":"Eur J Pharmacol"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF02245648","volume":"104","author":"KA Grant","year":"1991","unstructured":"Grant KA, Barrett JE: Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists. Psychopharmacology 104:451\u2013456, 1991.","journal-title":"Psychopharmacology"},{"key":"18_CR45","first-page":"870P","volume":"95","author":"NR Oakley","year":"1988","unstructured":"Oakley NR, Jones BJ, Tyers MB, et al: The effect of GR38032F on alcohol consumption in the marmoset. Br J Pharmacol 95:870P, 1988.","journal-title":"Br J Pharmacol"},{"key":"18_CR46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/oxfordjournals.alcalc.a045088","volume":"26","author":"F Fadda","year":"1991","unstructured":"Fadda F, Garau B, Marchel F, et al: MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol 26:107\u2013110, 1991.","journal-title":"Alcohol"},{"key":"18_CR47","first-page":"495S","volume":"29","author":"EM Sellers","year":"1991","unstructured":"Sellers EM, Romach MK, Toneatto T, et al: Efficacy of ondansetron, a 5-HT3 antagonist, in alcoholism treatment. Biol Psychiatry 29:495S, 1991.","journal-title":"Biol Psychiatry"},{"key":"18_CR48","first-page":"382","volume":"15","author":"T Toneatto","year":"1991","unstructured":"Toneatto T, Romach MK, Sobell LC, et al: Ondansetron, a 5-HT3 antagonist, reduces alcohol consumption in alcohol abusers. Alcoholism Clin Exp Res 15:382, 1991.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/0006-8993(86)90299-4","volume":"378","author":"C Idzikowski","year":"1986","unstructured":"Idzikowski C, Mills FJ, Glennard R: 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res 378:164\u2013168, 1986.","journal-title":"Brain Res"},{"key":"18_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ddr.430080123","volume":"8","author":"TF Meert","year":"1986","unstructured":"Meert TF: A comparative study of the effects of ritanserin (R 55 667) and chlordiazepoxide on rat open field behavior. Drug Dev Res 8:197\u2013204, 1986.","journal-title":"Drug Dev Res"},{"key":"18_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ddr.430080124","volume":"8","author":"A Reyntjens","year":"1986","unstructured":"Reyntjens A, Gelders YG, Hoppenbrouwers JA, et al: Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 receptor blocker. Drug Dev Res 8:205\u2013211, 1986.","journal-title":"Drug Dev Res"},{"key":"18_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ddr.430180204","volume":"18","author":"TF Meert","year":"1989","unstructured":"Meert TF, Janssen PAJ: Psychopharmacology of ritanserin: Comparison with chlordiazepoxide. Drug Dev Res 18:119\u2013144, 1989.","journal-title":"Drug Dev Res"},{"key":"18_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-2007-1014461","volume":"24","author":"TF Meert","year":"1991","unstructured":"Meert TF, Awouters F, Niemegeers CJE, et al: Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats. Pharmacopsychiatry 24:159\u2013163, 1991.","journal-title":"Pharmacopsychiatry"},{"key":"18_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ddr.430240305","volume":"24","author":"TF Meert","year":"1991","unstructured":"Meert TF, Janssen PAJ: Ritanserin, a new therapeutic approach for drug abuse. Drug Dev Res 24:235\u2013249 1991.","journal-title":"Drug Dev Res"},{"key":"18_CR55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ddr.430150107","volume":"15","author":"F Awouters","year":"1988","unstructured":"Awouters F, Niemegeers CJE, Megens AAHP, et al: Pharmacological profile of ritanserin: A very specific central serotonin S2-antagonist. Drug Dev Res 15:61\u201373, 1988.","journal-title":"Drug Dev Res"},{"key":"18_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0140-6736(91)93386-N","volume":"337","author":"JM Monti","year":"1991","unstructured":"Monti JM, Alterwain P: Ritanserin decreases alcohol intake in chronic alcoholics. Lancet 337:60, 1991.","journal-title":"Lancet"},{"issue":"12","key":"18_CR57","first-page":"3","volume":"52","author":"HY Meltzer","year":"1991","unstructured":"Meltzer HY: Introduction: Multiple roles and actions of serotonin systems; J Clin Psychiatry 52(suppl 12):3, 1991.","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"18_CR58","first-page":"70","volume":"52","author":"HY Meltzer","year":"1991","unstructured":"Meltzer HY: Summary: The significance of serotonin for neuropsychiatric disorders. J Clin Psychiatry 52(suppl 12):70\u201372, 1991.","journal-title":"J Clin Psychiatry"},{"key":"18_CR59","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/BF01940430","volume":"43","author":"K Blum","year":"1987","unstructured":"Blum K, Briggs AH, Wallace JE, et al: Regional brain [Met]-enkephalin in alcohol-preferring and non-alcohol-preferring inbred strains of mice. Experientia 43:408\u2013410, 1987.","journal-title":"Experientia"},{"key":"18_CR60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.2042-7158.1982.tb04199.x","volume":"34","author":"AKS Ho","year":"1982","unstructured":"Ho AKS, Rossi N: Suppression of ethanol consumption by MET-enkephalin in rats. J Pharm Pharmacol 34:118\u2013119, 1982.","journal-title":"J Pharm Pharmacol"},{"key":"18_CR61","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0031-9384(90)90340-A","volume":"48","author":"C Sandi","year":"1990","unstructured":"Sandi C, Borrell J, Guaza C: D-Ala2-Met5-enkephalinamide impairs the acquisition of ethanol preference without influencing sucrose preference. Physiol Behav 48:435\u2013439, 1990.","journal-title":"Physiol Behav"},{"key":"18_CR62","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1530-0277.1991.tb00576.x","volume":"15","author":"SR George","year":"1991","unstructured":"George SR, Roldan L, Lui A, et al: Endogenous opioids are involved in the genetically determined high preference for ethanol consumption. Alcoholism Clin Exp Res 15:668\u2013672, 1991.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/BF02244246","volume":"103","author":"JC Froehlich","year":"1991","unstructured":"Froehlich JC, Zweifel M, Harts J, et al: Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103:467\u2013472, 1991.","journal-title":"Psychopharmacology"},{"key":"18_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0091-3057(74)90088-4","volume":"2","author":"JD Sinclair","year":"1974","unstructured":"Sinclair JD: Morphine suppresses alcohol drinking regardless of prior alcohol access duration. Pharmacol Biochem Behav 2:409\u2013412, 1974.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR65","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0741-8329(86)90070-4","volume":"3","author":"CL Hubbell","year":"1986","unstructured":"Hubbell CL, Czirr SA, Hunter GA, et al: Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3:39\u201354, 1986.","journal-title":"Alcohol"},{"key":"18_CR66","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0091-3057(89)90523-6","volume":"33","author":"MA Linseman","year":"1989","unstructured":"Linseman MA: Central vs. peripheral mediation of opioid effects on alcohol consumption in free-feeding rats. Pharmacol Biochem Behav 33:407\u2013413, 1989.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR67","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0741-8329(91)90305-G","volume":"8","author":"LD Reid","year":"1991","unstructured":"Reid LD, Delconte JD, Nichols ML, et al: Tests of opioid deficiency hypotheses of alcoholism. Alcohol 8:247\u2013257, 1991.","journal-title":"Alcohol"},{"key":"18_CR68","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0741-8329(91)90401-H","volume":"8","author":"JR Volpicelli","year":"1991","unstructured":"Volpicelli JR, Ulm RR, Hopson N: Alcohol drinking in rats during and following morphine injections. Alcohol 8:289\u2013292, 1991.","journal-title":"Alcohol"},{"key":"18_CR69","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0028-3908(82)90038-7","volume":"21","author":"PL Wood","year":"1982","unstructured":"Wood PL: Multiple opiate receptors: Support for unique mu, delta and kappa sites. Neurophar-macology 21:487\u2013497, 1982.","journal-title":"Neurophar-macology"},{"key":"18_CR70","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/0024-3205(88)90562-0","volume":"42","author":"C Sandi","year":"1988","unstructured":"Sandi C, Borrell J, Guaza C: Involvement of kappa type opioids on ethanol drinking. Life Sci 42:1067\u20131075, 1988.","journal-title":"Life Sci"},{"key":"18_CR71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4613-9000-8_13","volume-title":"Opioids, Bulimia and Alcohol Abuse and Alcoholism","author":"C Gianoulakis","year":"1990","unstructured":"Gianoulakis C, Angelogianni P, Meaney M, et al: Endorphins in individuals with high and low risk for development of alcoholism, in Reid LD (ed): Opioids, Bulimia and Alcohol Abuse and Alcoholism. Berlin, Springer-Verlag, 1990. pp 229\u2013246."},{"key":"18_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0741-8329(91)90573-F","volume":"8","author":"CL Hubbell","year":"1991","unstructured":"Hubbell CL, Marglin SH, Spitalnic SJ, et al: Opioidergic, serotonergic, and dopaminergic manipulations and rats\u2019 intake of a sweetened alcoholic beverage. Alcohol 8:355\u2013367, 1991.","journal-title":"Alcohol"},{"key":"18_CR73","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0741-8329(86)90058-3","volume":"3","author":"RD Myers","year":"1986","unstructured":"Myers RD, Borg S, Mossberg R: Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol 3:383\u2013388, 1986.","journal-title":"Alcohol"},{"key":"18_CR74","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0024-3205(86)90601-6","volume":"38","author":"JR Volpicelli","year":"1986","unstructured":"Volpicelli JR, Davis MA, Olgin JE: Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci 38:841\u2013847, 1986.","journal-title":"Life Sci"},{"key":"18_CR75","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0091-3057(88)90323-1","volume":"31","author":"L Pulvirenti","year":"1988","unstructured":"Pulvirenti L, Kastin AJ: Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: Correlation with degree of spontaneous preference. Pharmacol Biochem Behav 31:129\u2013134, 1988.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4613-9000-8_12","volume-title":"Opioids, Bulimia, and Alcohol Abuse and Alcoholism","author":"JC Froehlich","year":"1990","unstructured":"Froehlich JC, Li T-K: Enkephalinergic involvement in voluntary drinking of alcohol, in Reid LD (ed): Opioids, Bulimia, and Alcohol Abuse and Alcoholism. Berlin, Springer-Verlag, 1990. pp 217\u2013228."},{"key":"18_CR77","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0091-3057(90)90174-G","volume":"35","author":"JC Froehlich","year":"1990","unstructured":"Froehlich JC, Harts J, Lumeng L, et al: Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385\u2013390, 1990.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4613-9000-8_11","volume-title":"Opioids, Bulimia, and Alcohol Abuse and Alcoholism","author":"JR Volpicelli","year":"1990","unstructured":"Volpicelli JR, O\u2019Brien CP, Alterman AI, et al: Naltrexone and the treatment of alcohol-dependence: Initial observations, in Reid LD (ed): Opioids, Bulimia, and Alcohol Abuse and Alcoholism. Berlin, Springer-Verlag, 1990. pp 195\u2013214."},{"key":"18_CR79","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, et al: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876\u2013880, 1992.","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR80","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","volume":"49","author":"SS O\u2019Malley","year":"1992","unstructured":"O\u2019Malley SS, Jaffe A, Chang G, et al: Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 49:881\u2013887, 1992.","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR81","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0091-3057(79)90043-1","volume":"11","author":"DR Brown","year":"1979","unstructured":"Brown DR, Holtzman SG: Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacol Biochem Behav 11:567\u2013573, 1979.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR82","first-page":"R91","volume":"251","author":"M Fantino","year":"1986","unstructured":"Fantino M, Hosotte J, Apfelbaum M: An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am J Physiol 251:R91\u2013R96, 1986.","journal-title":"Am J Physiol"},{"key":"18_CR83","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0091-3057(87)90158-4","volume":"26","author":"TC Kirkham","year":"1987","unstructured":"Kirkham TC, Blundell JE: Effects of naloxone and naltrexone on meal patterns of freely-feeding rats. Pharmacol Biochem Behav 26:515\u2013520, 1987.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR84","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF02244123","volume":"101","author":"F Weiss","year":"1990","unstructured":"Weiss F, Mitchiner M, Bloom FE, et al: Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology 101:178\u2013186, 1990.","journal-title":"Psychopharmacology"},{"key":"18_CR85","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/978-1-4612-2878-3_13","volume-title":"Novel Pharmacological Interventions for Alcoholism","author":"SS O\u2019Malley","year":"1992","unstructured":"O\u2019Malley SS, Jaffe A, Chang G, et al: Naltrexone in the treatment of alcohol dependence: Preliminary findings, in Narango CA, Sellers EM (eds): Novel Pharmacological Interventions for Alcoholism. Berlin, Springer-Verlag, 1992. pp 148\u2013160."},{"key":"18_CR86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0361-9230(84)90190-4","volume":"12","author":"RA Wise","year":"1984","unstructured":"Wise RA, Bozarth MA: Brain reward circuitry: Four circuit elements \u201cwired\u201d in apparent series. Brain Res Bull 12:203\u2013208, 1984.","journal-title":"Brain Res Bull"},{"key":"18_CR87","first-page":"219","volume":"239","author":"A Imperato","year":"1986","unstructured":"Imperato A, De Chiara G: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239:219\u2013228, 1986.","journal-title":"J Pharmacol Exp Ther"},{"key":"18_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0006-8993(91)90489-I","volume":"540","author":"KM Wozniak","year":"1991","unstructured":"Wozniak KM, Pert A, Mele A, et al: Focal application of alcohols elevates extracellular dopamine in rat brain: A microdialysis study. Brain Res 540:31\u201340, 1991.","journal-title":"Brain Res"},{"key":"18_CR89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0741-8329(91)90854-P","volume":"8","author":"SD Quarbordt","year":"1991","unstructured":"Quarbordt SD, Kalmus GW, Myers RD: Ethanol drinking following 6-OHDA lesions of nucleus accumbens and tuberculum olfactorium of the rat. Alcohol 8:211\u2013217, 1991.","journal-title":"Alcohol"},{"key":"18_CR90","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1530-0277.1992.tb00639.x","volume":"16","author":"JI Balldin","year":"1992","unstructured":"Balldin JI, Berggren UC, Lindstedt G: Neuroendocrine evidence for reduced dopamine receptor sensitivity in alcoholism. Alcoholism Clin Exp Res 16:71\u201374, 1992.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR91","first-page":"417","volume":"1","author":"AD Levy","year":"1991","unstructured":"Levy AD, Murphy JM, McBride WJ, et al: Microinjection of sulpiride into the nucleus accumbens increases ethanol drinking in alcohol-preferring (P) rats. Alcohol Suppl 1:417\u2013420, 1991.","journal-title":"Alcohol Suppl"},{"key":"18_CR92","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF02244405","volume":"100","author":"MA Linseman","year":"1990","unstructured":"Linseman MA: Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm. Psychopharmacology 100:195\u2013200, 1990.","journal-title":"Psychopharmacology"},{"key":"18_CR93","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1600-0447.1983.tb06987.x","volume":"68","author":"V Borg","year":"1983","unstructured":"Borg V: Bromocriptine in the prevention of alcohol abuse. Acta Psychiatr Scand 68:100\u2013110, 1983.","journal-title":"Acta Psychiatr Scand"},{"key":"18_CR94","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1530-0277.1991.tb05197.x","volume":"15","author":"M Dongier","year":"1991","unstructured":"Dongier M, Vachon L, Schwartz G: Bromocriptine in the treatment of alcohol dependence. Alcoholism Clin Exp Res 15:970\u2013977, 1991.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0091-3057(88)90167-0","volume":"29","author":"AO Pfeffer","year":"1988","unstructured":"Pfeffer AO, Samson HH: Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats. Pharmacol Biochem Behav 29:343\u2013350, 1988.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR96","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1096\/fasebj.4.5.2155149","volume":"4","author":"RW Olsen","year":"1990","unstructured":"Olsen RW, Tobin AJ: Molecular biology of GABAA receptors. FASEB J 4:1469\u20131480, 1990.","journal-title":"FASEB J"},{"key":"18_CR97","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0091-3057(88)90487-X","volume":"30","author":"MK Ticku","year":"1988","unstructured":"Ticku MK, Kulkarni SK: Molecular interactions of ethanol with GABAergic system and potential of RO 15-4513 as an ethanol antagonist. Pharmacol Biochem Behav 30:501\u2013510, 1988.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR98","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4899-1678-5_15","volume-title":"Recent Developments in Alcoholism","author":"D Nutt","year":"1989","unstructured":"Nutt D, Adinoff B, Linnoila M: Benzodiazepines in the treatment of alcoholism, in Galanter M (ed): Recent Developments in Alcoholism. New York, Plenum Press, 1989. vol 7, pp 283\u2013313."},{"key":"18_CR99","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1530-0277.1990.tb01188.x","volume":"14","author":"BH Hwang","year":"1990","unstructured":"Hwang BH, Lumeng L, Wu J-Y, et al: Increased number of GABAergic terminals in the nucleus accumbens is associated with alcohol preference in rats. Alcoholism Clin Exp Res 14:503\u2013507, 1990.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR100","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1300\/J251v07n03_19","volume":"7","author":"RG Lister","year":"1988","unstructured":"Lister RG, Nutt DJ: RO 15-4513 and its interaction with ethanol. Adv Alcohol Substance Abuse 7:119\u2013123, 1988.","journal-title":"Adv Alcohol Substance Abuse"},{"key":"18_CR101","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0091-3057(87)90357-1","volume":"27","author":"HH Samson","year":"1987","unstructured":"Samson HH, Tolliver GA, Pfeffer AO, et al: Oral ethanol reinforcement in the rat: Effect of the partial inverse benzodiazepine agonist RO 15-4513. Pharmacol Biochem Behav 27:517\u2013519, 1987.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR102","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1530-0277.1991.tb00538.x","volume":"15","author":"HL June","year":"1991","unstructured":"June HL, Lummis GH, Colker RE, et al: RO 15-4513 attenuates the consumption of ethanol in deprived rats. Alcoholism Clin Exp Res 15:406\u2013411, 1991.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1530-0277.1992.tb00628.x","volume":"16","author":"HL June","year":"1992","unstructured":"June HL, Colker RE, Domangue KR, et al: Ethanol self-administration in deprived rats: Effects of RO 15-4513 alone, and in combination with flumazenil (RO 15-1788). Alcoholism Clin Exp Res 16:11\u201316, 1992.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR104","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0166-2236(87)90160-3","volume":"10","author":"RG Lister","year":"1987","unstructured":"Lister RG, Nutt DJ: Is RO 15-4513 a specific alcohol antagonist? Trends Neurosci 10:223\u2013225, 1987.","journal-title":"Trends Neurosci"},{"key":"18_CR105","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(85)91615-0","volume":"1","author":"JP Lhuintre","year":"1985","unstructured":"Lhuintre JP, Daouist M, Moore ND, et al: Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet 1:1014\u20131016, 1985.","journal-title":"Lancet"},{"key":"18_CR106","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/oxfordjournals.alcalc.a045057","volume":"25","author":"JP Lhuintre","year":"1990","unstructured":"Lhuintre JP, Moore N, Tran G, et al: Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcoholism 25:613\u2013622, 1990.","journal-title":"Alcohol Alcoholism"},{"key":"18_CR107","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1126\/science.7268421","volume":"213","author":"S Borg","year":"1981","unstructured":"Borg S, Kvande H, Sedvall G: Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science 213:1135\u20131137, 1981.","journal-title":"Science"},{"key":"18_CR108","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-0404.1986.tb07833.x","volume":"73","author":"S Borg","year":"1986","unstructured":"Borg S, Lijeberg P, Mossberg D: Clinical studies on central noradrenergic activity in alcohol abusing patients. Acta Psychiatr Scan Suppl 73:43\u201360, 1986.","journal-title":"Acta Psychiatr Scan Suppl"},{"key":"18_CR109","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0741-8329(84)90007-7","volume":"1","author":"M Daoust","year":"1984","unstructured":"Daoust M, Saligaut C, Chadelaud M, et al: Attenuation by antidepressant drugs of alcohol intake in rats. Alcohol 1:379\u2013383, 1984.","journal-title":"Alcohol"},{"key":"18_CR110","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0741-8329(85)90073-4","volume":"2","author":"JM Murphy","year":"1985","unstructured":"Murphy JM, Waller MB, Gatto GJ, et al: Monoamine uptake inhibitors attenuate ethanol intake in alcohol-preferring (P) rats. Alcohol 2:349\u2013352, 1985.","journal-title":"Alcohol"},{"key":"18_CR111","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0165-0327(84)90031-4","volume":"7","author":"GH Berken","year":"1984","unstructured":"Berken GH, Weinstein DO, Stern WC: Weight gain: A side-effect of tricyclic antidepressants. J Affect Disord 7:133\u2013138, 1984.","journal-title":"J Affect Disord"},{"key":"18_CR112","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0091-3057(87)90484-9","volume":"27","author":"JN Nobrega","year":"1987","unstructured":"Nobrega JN, Coscina DV: Effects of chronic amitriptyline and desipramine on food intake and body weight in rats. Pharmacol Biochem Behav 27:105\u2013112, 1987.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR113","first-page":"155","volume":"27","author":"BJ Mason","year":"1991","unstructured":"Mason BJ, Kocsis JH: Desipramine treatment of alcoholism. Psychopharmacol Bull 27:155\u2013161, 1991.","journal-title":"Psychopharmacol Bull"},{"key":"18_CR114","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1530-0277.1992.tb01385.x","volume":"16","author":"AH Rezvani","year":"1992","unstructured":"Rezvani AH, Garbutt JC, Shimoda K, et al: Attenuation of alcohol preferences in alcohol preferring rats by a novel TRH analogue TA-0910. Alcoholism Clin Exp Res 16:326\u2013330, 1992.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR115","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0028-3908(79)90005-4","volume":"18","author":"DJ Heal","year":"1979","unstructured":"Heal DJ, Green AR: Administration of thyrotropin releasing hormone (TRH) to rats releases dopamine in n. accumbens but not n. caudatus. Neuropharmacology 18:23\u201331, 1979.","journal-title":"Neuropharmacology"},{"key":"18_CR116","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0028-3908(81)90181-7","volume":"20","author":"H Barbeau","year":"1981","unstructured":"Barbeau H, Bedard P: Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5,7-dehydroxytryptamine injections. Neuropharmacology 20:477\u2013481, 1981.","journal-title":"Neuropharmacology"},{"key":"18_CR117","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0741-8329(89)90010-4","volume":"6","author":"PJ Kulkosky","year":"1989","unstructured":"Kulkosky PJ, Sanchez MR, Foderaro MA, et al: Cholecystokinin and satiation with alcohol. Alcohol 6:395\u2013402, 1989.","journal-title":"Alcohol"},{"key":"18_CR118","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3758\/BF03333965","volume":"29","author":"PJ Kulkosky","year":"1991","unstructured":"Kulkosky PJ, Holst WE, Smith WG, et al: Effect of CCK-8 on intake of caffeine, ethanol, and water. Bull Psychon Soc 29:441\u2013444, 1991.","journal-title":"Bull Psychon Soc"},{"key":"18_CR119","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.2781294","volume":"245","author":"CT Dourish","year":"1989","unstructured":"Dourish CT, Rycroft W, Iversen SD: Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 245:1509\u20131511, 1989.","journal-title":"Science"},{"key":"18_CR120","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0741-8329(91)90663-H","volume":"8","author":"S Krishnan","year":"1991","unstructured":"Krishnan S, Nash JF, Maickel RP: Free-choice ethanol consumption by rats: Effects of ACTH4\u201310. Alcohol 8:401\u2013404, 1991.","journal-title":"Alcohol"},{"key":"18_CR121","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/0024-3205(91)90643-P","volume":"49","author":"S Krishnan","year":"1991","unstructured":"Krishnan S, Maickel RP: The effect of Hoe-427 (an ACTH4\u20139 analog) on free-choice ethanol consumption in male and female rats. Life Sci 49:2005\u20132011, 1991.","journal-title":"Life Sci"},{"key":"18_CR122","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/0091-3057(89)90081-6","volume":"32","author":"LA Grupp","year":"1989","unstructured":"Grupp LA, Kalant H, Leenen FHH: Alcohol intake is inversely related to plasma renin activity in the genetically selected alcohol-preferring and-nonpreferring lines of rats. Pharmacol Biochem Behav 32:1061\u20131063, 1989.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR123","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0091-3057(88)90007-X","volume":"29","author":"LA Grupp","year":"1988","unstructured":"Grupp LA, Killian M, Perlanski E, et al: Angiotensin II reduces voluntary alcohol intake in the rat. Pharmacol Biochem Behav 29:479\u2013482, 1988.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR124","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0091-3057(88)90389-9","volume":"31","author":"LA Grupp","year":"1989","unstructured":"Grupp LA, Perlanski E, Stewart RB: Angiotensin II-induced suppression of alcohol intake and its reversal by the angiotensin antagonist Sar-1 Thr-8 angiotensin II. Pharmacol Biochem Behav 31:813\u2013816 1989.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR125","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1530-0277.1990.tb00453.x","volume":"14","author":"T Lingham","year":"1990","unstructured":"Lingham T, Perlanski E, Grupp LA: Angiotensin converting enzyme inhibitors reduce alcohol consumption: Some possible mechanisms and important conditions for its therapeutic use. Alcoholism Clin Exp Res 14:92\u201399, 1990.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR126","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0091-3057(89)90374-2","volume":"34","author":"LA Grupp","year":"1989","unstructured":"Grupp LA, Perlanski E, Stewart RB: Systemic angiotensin II acts at the subfornical organ to suppress voluntary alcohol consumption. Pharmacol Biochem Behav 34:201\u2013205, 1989.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR127","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1530-0277.1988.tb00134.x","volume":"12","author":"G Spinosa","year":"1988","unstructured":"Spinosa G, Perlanski E, Leenen FHH, et al: Angiotensin converting enzyme inhibitors: Animal experiments suggest a new pharmacological treatment for alcohol abuse in humans. Alcoholism Clin Exp Res 12:65\u201370, 1988.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR128","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/clpt.1991.108","volume":"50","author":"CA Naranjo","year":"1991","unstructured":"Naranjo CA, Kadlec KE, Sanhueza P, et al: Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics. Clin Pharmacol Ther 50:96\u2013106, 1991.","journal-title":"Clin Pharmacol Ther"},{"key":"18_CR129","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1530-0277.1991.tb00533.x","volume":"15","author":"BF O\u2019Dowd","year":"1991","unstructured":"O\u2019Dowd BF, Grupp LA: The influence of the renin gene on alcohol consumption in Dahl rats. Alcoholism Clin Exp Res 15:145\u2013149, 1991.","journal-title":"Alcoholism Clin Exp Res"},{"key":"18_CR130","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0031-9384(80)90287-5","volume":"25","author":"D Smith","year":"1980","unstructured":"Smith D, Oei TPS, Ng KT, et al: Rat self administration of ethanol: Enhancement by darkness and exogenous melatonin. Physiol Behav 25:449\u2013455, 1980.","journal-title":"Physiol Behav"},{"key":"18_CR131","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0091-3057(81)90234-3","volume":"14","author":"PK Rudeen","year":"1981","unstructured":"Rudeen PK, Symmes SK: Pineal gland and melatonin influence on chronic alcohol consumption by hamsters. Pharmacol Biochem Behav 14:143\u2013147, 1981.","journal-title":"Pharmacol Biochem Behav"},{"key":"18_CR132","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1749-6632.1989.tb22624.x","volume":"559","author":"F George","year":"1989","unstructured":"George F: The role of arachidonic metabolites in mediating ethanol self-administration and intoxication. Ann NY Acad Sci 559:382\u2013391, 1989.","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"18_CR133","doi-asserted-by":"crossref","first-page":"167","DOI":"10.15288\/jsa.1988.49.167","volume":"49","author":"TF Babor","year":"1988","unstructured":"Babor TF, Dolinsky Z, Rousaville B, et al: Unitary versus multidimensional models of alcoholism treatment outcome: An empirical study. Alcohol 49(2):167\u2013177, 1988.","journal-title":"Alcohol"},{"key":"18_CR134","volume-title":"Introduction to Structural Equation Models","author":"O Duncan","year":"1975","unstructured":"Duncan O: Introduction to Structural Equation Models. New York, Academic Press, 1975."}],"container-title":["Recent Developments in Alcoholism"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-1742-3_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T10:51:59Z","timestamp":1557917519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-1742-3_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"ISBN":["9781489917447","9781489917423"],"references-count":134,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-1742-3_18","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4899-1742-3","asserted-by":"object"}]},"ISSN":["0738-422X"],"issn-type":[{"value":"0738-422X","type":"print"}],"subject":[],"published":{"date-parts":[[1993]]}}}